Alpha Teknova (TKNO) Share-based Compensation (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Share-based Compensation came in at $5.3 million in Q1 2026, up 522.07% year-on-year from $852000.0 in Q1 2025, and up 582.11% on a QoQ basis from $777000.0 in Q4 2025.
Alpha Teknova (TKNO) Share-based Compensation (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Share-based Compensation data on file, last reported at $5.3 million in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 522.07% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $5.3 million, a 65.06% increase from a year earlier, with the FY2025 full-year figure at $4.6 million, up 25.48% from the prior year.
- Share-based Compensation for Q1 2026 stood at $5.3 million, up from $777000.0 in the prior quarter.
- Over the last five years, Share-based Compensation for TKNO reached as high as $5.3 million in Q1 2026 and fell as low as $385000.0 in Q4 2023.
- Historically, Share-based Compensation has averaged $1.2 million across 5 years, with a median of $934000.0 in 2022.
- Across the five-year window, Share-based Compensation slumped 62.33% in 2023 and surged 522.07% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $1.0 million in 2022, then slumped by 62.33% to $385000.0 in 2023, then surged by 98.96% to $766000.0 in 2024, then rose by 1.44% to $777000.0 in 2025, then jumped by 582.11% to $5.3 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $5.3 million in Q1 2026, $777000.0 in Q4 2025, and $850000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.30 Mn |
| Mar 31, 2026 | 5.30 Mn |
| Dec 31, 2025 | 777,000.00 |
| Dec 31, 2025 | 777,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Mar 31, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 385,000.00 |
| Dec 31, 2023 | 385,000.00 |